• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Brain Cancer Global Clinical Trials Review, Q4, 2010 - Product Image

Brain Cancer Global Clinical Trials Review, Q4, 2010

  • ID: 1496210
  • December 2010
  • Region: Global
  • 89 pages
  • GlobalData

Brain Cancer Global Clinical Trials Review, Q4, 2010

Summary

Our clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Brain Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Brain Cancer).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
Introduction
Brain Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Brain Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Brain Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Alberta Health Services
Clinical Trial Overview of Alberta Health Services
Neopharm Ltd.
Clinical Trial Overview of Neopharm Ltd.
Barrett Cancer Center
Clinical Trial Overview of Barrett Cancer Center
Novartis AG
Clinical Trial Overview of Novartis AG
Direct Therapeutics, Inc.
Clinical Trial Overview of Direct Therapeutics, Inc.
Celtic Pharmaceutical Holdings L.P.
Clinical Trial Overview of Celtic Pharmaceutical Holdings L.P.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
BTG plc
Clinical Trial Overview of BTG plc
Advocate Health Care
Clinical Trial Overview of Advocate Health Care
Neurocrine Biosciences, Inc.
Clinical Trial Overview of Neurocrine Biosciences, Inc.
Aposense Ltd.
Clinical Trial Overview of Aposense Ltd.
MediGene AG
Clinical Trial Overview of MediGene AG
YM BioSciences Inc.
Clinical Trial Overview of YM BioSciences Inc.
SkyePharma PLC
Clinical Trial Overview of SkyePharma PLC
Grifols, S.A.
Clinical Trial Overview of Grifols, S.A.
Nexstim Oy
Clinical Trial Overview of Nexstim Oy
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
medac GmbH
Clinical Trial Overview of medac GmbH
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Duke University
Clinical Trial Overview of Duke University
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
North Central Cancer Treatment Group
Clinical Trial Overview of North Central Cancer Treatment Group
Stanford University
Clinical Trial Overview of Stanford University
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
New York University School of Medicine
Clinical Trial Overview of New York University School of Medicine
Wake Forest University
Clinical Trial Overview of Wake Forest University
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos